Clinical Trials in Maryland

Showing 7061-7080 of 23,284 trials

Study of Selinexor Plus DRd for Newly Diagnosed Multiple Myeloma

NCT04782687

This is a single-arm, phase II, open-label trial to investigate the effects of selinexor (S) in combination with daratumumab, lenalidomide, and dexamethasone (DRd) for first-line treatment of multiple myeloma (MM). FDA has approved selinexor plus dexamethasone in multiple myeloma after four prior therapies, and DRd is also already approved by the FDA for multiple myeloma. This study will use all four (S-DRd) together to treat MM as an initial treatment.

Multiple MyelomaMyeloma MultipleKahler Disease+4 more

US Oncology Research73 participantsStarted Sep 2021

Tucson, Arizona, United States • Denver, Colorado, United States • Columbia, Maryland, United States +7 more locations

COMPLETEDPhase 417 miles

Safety and Treatment Satisfaction in Adults With Chronic ITP After Switching to Avatrombopag From Eltrombopag or Romiplostim

NCT04638829

Evaluate the safety and tolerability of avatrombopag given for 90 days after stopping treatment with eltrombopag or romiplostim.

Immune Thrombocytopenia

Sobi, Inc.60 participantsStarted Mar 2021

Tucson, Arizona, United States • Whittier, California, United States • Washington D.C., District of Columbia, United States +17 more locations

Study of Selinexor Plus DRd for Newly Diagnosed Multiple Myeloma

Safety and Treatment Satisfaction in Adults With Chronic ITP After Switching to Avatrombopag From Eltrombopag or Romiplostim

Find Trials by Condition in Maryland

Effects of a New Behavioral Intervention on Alcohol Craving and Drinking

Differences in Corneal Structure and Function in Patients With Sjogrens vs. Non-Sjogrens Dry Eye

Manipulating Ghrelin Signaling Via GOAT Inhibition in Alcohol Use Disorder

Safety, Tolerability, and Pharmacokinetics of a Single Intravenous Infusion of XTMAB-16 in Healthy Adult Participants

Study to Assess the Efficacy and Safety of NBI-1065845 in Adults With Major Depressive Disorder (MDD)

CLUSTER Trial for Outbreak Detection and Response

ACX-362E [Ibezapolstat] for Oral Treatment of Clostridioides Difficile Infection

Azacitidine With or Without Nivolumab or Midostaurin, or Decitabine and Cytarabine Alone in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

PERSEVERE- A Trial to Evaluate AMDS in Acute DeBakey Type I Dissection

A Study to Assess Overall Response Rate by Inducing an Inflammatory Phenotype in Metastatic BReast cAnCEr With the Oncolytic Reovirus PeLareorEp in CombinaTion With Anti-PD-L1 Avelumab and Paclitaxel - BRACELET-1 Study

Automated Insulin Delivery in Elderly With Type 1 Diabetes (AIDE T1D)

A Study to Evaluate the Safety, and Tolerability, and Efficacy of Seladelpar in Patients With PSC

Clinical Evaluation of the StablePoint Catheter and Force Sensing System for Paroxysmal Atrial Fibrillation

Saypha® VOLUME Lidocaine for Midface Augmentation

The Syn-Sleep Study

Evaluating Treatment of ADHD in Children with Down Syndrome

Feasibility Study of Intraoperative Detection of Residual Cancer in Breast Cancer Patients

Safety of a Three-Day Fosaprepitant Regimen for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Pediatric Participants (MK-0517-045)